...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Reversible, complete atrioventricular block caused by primary cardiac lymphoma in a nonimmunocompromised patient
【24h】

Reversible, complete atrioventricular block caused by primary cardiac lymphoma in a nonimmunocompromised patient

机译:非免疫功能低下患者原发性心脏淋巴瘤引起的可逆性完全房室传导阻滞

获取原文
获取原文并翻译 | 示例
           

摘要

Primary cardiac lymphoma (PCL) is a rare entity that commonly presents as a heart rhythm disorder. We describe a previously healthy, immunocompetent patient presenting with complete atrioventricular block (AVB). The patient was found to have a cardiac mass on magnetic resonance imaging and underwent percutaneous biopsy eventually diagnosing PCL. After pacemaker implantation, the patient's tumor responded rapidly to chemotherapy and the AVB completely resolved. In otherwise healthy patients presenting with AV block, cardiac tumor should be considered. Additionally, if PCL is diagnosed and the patient is clinically stable with AVB, it may be reasonable to delay pacemaker implantation until the clinical response to chemotherapy is evaluated.
机译:原发性心脏淋巴瘤(PCL)是一种罕见的实体,通常表现为心律失常。我们描述了一个完整的房室传导阻滞(AVB)的先前健康,具有免疫能力的患者。该患者在磁共振成像中发现心脏肿块,并进行了经皮穿刺活检,最终诊断出PCL。植入起搏器后,患者的肿瘤对化疗反应迅速,AVB完全消退。在其他出现AV阻滞的健康患者中,应考虑心脏肿瘤。另外,如果诊断出PCL且患者使用AVB在临床上稳定,则延迟起搏器植入直至评估对化学疗法的临床反应可能是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号